Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of Internal Medicine
Among adults with likely long COVID one year after infection, an estimated half met the study’s primary improvement criterion by three years. Approximately a quarter reported no symptoms contributing to the Long COVID Research Index.
Family Medicine/General Practice November 19th 2026
Neurology Advisor
Cala Health announced nationwide availability of its FDA-cleared wearable for adults with essential tremor and Parkinson’s disease. The prescription system offers three stimulation modes for temporary relief of specified hand tremor symptoms.
Neurology November 17th 2026
Brain Communications
Twice-weekly resistance training did not significantly change whole-brain white matter hyperintensity volume versus balance-and-tone exercise in adults with subcortical vascular cognitive impairment. Regional differences favored resistance training, but these exploratory findings require confirmation.
Geriatric Nursing November 17th 2026
In an adaptive randomized trial of adults with long COVID, fluvoxamine modestly reduced fatigue and improved quality-of-life scores through 90 days, while metformin findings remained inconclusive after dose modification and early termination.
Family Medicine/General Practice October 16th 2026
News Medical
Personalized models using wearable data forecast sedentary bouts in women with chronic pelvic pain, primarily endometriosis. Simpler models performed comparably to deep learning, but benefits from prediction-guided movement prompts remain untested.
Obstetrics & Gynecology October 14th 2026
Multiple Sclerosis News Today
Among individuals with progressive multiple sclerosis, higher blood neurofilament light chain (NfL) levels were associated with lower daily ambulatory activity, while increases in NfL over time tended to track with subsequent declines in step counts measured by wearable devices.
Neuroimmunology October 13th 2026